These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31440934)

  • 21. The emerging field of epigenetics in neurodegeneration and neuroprotection.
    Hwang JY; Aromolaran KA; Zukin RS
    Nat Rev Neurosci; 2017 May; 18(6):347-361. PubMed ID: 28515491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy.
    Gangisetty O; Murugan S
    Adv Neurobiol; 2016; 12():1-25. PubMed ID: 27651245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synapse elimination during development and disease: immune molecules take centre stage.
    Schafer DP; Stevens B
    Biochem Soc Trans; 2010 Apr; 38(2):476-81. PubMed ID: 20298206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How the epigenome integrates information and reshapes the synapse.
    Campbell RR; Wood MA
    Nat Rev Neurosci; 2019 Mar; 20(3):133-147. PubMed ID: 30696992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Essential Role of Epigenetic Modifications in Neurodegenerative Diseases with Dyskinesia.
    Qi Z; Li J; Li M; Du X; Zhang L; Wang S; Xu B; Liu W; Xu Z; Deng Y
    Cell Mol Neurobiol; 2022 Nov; 42(8):2459-2472. PubMed ID: 34383231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epigenetics of aging and neurodegeneration.
    Lardenoije R; Iatrou A; Kenis G; Kompotis K; Steinbusch HW; Mastroeni D; Coleman P; Lemere CA; Hof PR; van den Hove DL; Rutten BP
    Prog Neurobiol; 2015 Aug; 131():21-64. PubMed ID: 26072273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of activity in synaptic degeneration in a protein misfolding disease, prion disease.
    Caleo M; Restani L; Vannini E; Siskova Z; Al-Malki H; Morgan R; O'Connor V; Perry VH
    PLoS One; 2012; 7(7):e41182. PubMed ID: 22815961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
    Sahafnejad Z; Ramazi S; Allahverdi A
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synaptic dysfunction in synucleinopathies.
    Anichtchik O; Calo L; Spillantini MG
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1094-100. PubMed ID: 24040824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases.
    Mohd Murshid N; Aminullah Lubis F; Makpol S
    Cell Mol Neurobiol; 2022 Apr; 42(3):577-595. PubMed ID: 33074454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG and Non-CpG Methylation in the Diet-Epigenetics-Neurodegeneration Connection.
    Fuso A; Lucarelli M
    Curr Nutr Rep; 2019 Jun; 8(2):74-82. PubMed ID: 30887425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choline, the brain and neurodegeneration: insights from epigenetics.
    Bekdash RA
    Front Biosci (Landmark Ed); 2018 Jan; 23(6):1113-1143. PubMed ID: 28930592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of epigenetic modifications in neurodegenerative diseases.
    Qu W; Zhuang Y; Li X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):642-650. PubMed ID: 34986527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroepigenetics of ageing and neurodegeneration-associated dementia: An updated review.
    Mir FA; Amanullah A; Jain BP; Hyderi Z; Gautam A
    Ageing Res Rev; 2023 Nov; 91():102067. PubMed ID: 37689143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The UPR and synaptic dysfunction in neurodegeneration.
    Freeman OJ; Mallucci GR
    Brain Res; 2016 Oct; 1648(Pt B):530-537. PubMed ID: 27021956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shaping synaptic plasticity: the role of activity-mediated epigenetic regulation on gene transcription.
    Cortés-Mendoza J; Díaz de León-Guerrero S; Pedraza-Alva G; Pérez-Martínez L
    Int J Dev Neurosci; 2013 Oct; 31(6):359-69. PubMed ID: 23665156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases.
    Purro SA; Galli S; Salinas PC
    J Mol Cell Biol; 2014 Feb; 6(1):75-80. PubMed ID: 24449494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfunction and recovery of synapses in prion disease: implications for neurodegeneration.
    Moreno JA; Mallucci GR
    Biochem Soc Trans; 2010 Apr; 38(2):482-7. PubMed ID: 20298207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring Epigenetic Modifications as Potential Biomarkers and Therapeutic Targets in Glaucoma.
    Tonti E; Dell'Omo R; Filippelli M; Spadea L; Salati C; Gagliano C; Musa M; Zeppieri M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic mechanisms in memory and synaptic function.
    Sultan FA; Day JJ
    Epigenomics; 2011 Apr; 3(2):157-81. PubMed ID: 22122279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.